|
|
|||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 173
Evidence-Based Medicine and the Changing Nature of Health Care
Appendix A
Meeting Agenda
EVIDENCE-BASED MEDICINE AND THE CHANGING NATURE OF HEALTH CARE
THE NATIONAL ACADEMY OF SCIENCES BUILDING
2100 C STREET, N.W.
WASHINGTON, D.C.
MONDAY, OCTOBER 8
9:20 a.m.
INTRODUCTION OF THE PROGRAM
Mark B. McClellan, M.D., Ph.D., Senior Fellow and Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution
Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health
9:30 a.m.
WHAT FORCES ARE DRIVING THE NEED FOR BETTER MEDICAL EVIDENCE?
Chair: Denis A. Cortese, M.D., President and Chief
Executive Officer, Mayo Clinic
Relationship Between Health Care and the Evidence Base: Current Profile
Elliott S. Fisher, M.D., M.P.H., Professor of Medicine and Community and Family Medicine, Center for the Evaluative Clinical Sciences, Dartmouth Medical School
How the Pace of New Health Product Introduction Affects the Need for Evidence
Molly J. Coye, M.D., M.P.H., Founder and Chief Executive Officer, Health Technology Center
OCR for page 174
Evidence-Based Medicine and the Changing Nature of Health Care
How the Pace of New Insights into Genetic Variation Affects the Need for Evidence
David M. Altshuler, Ph.D., M.D., Director of Medical and Population Genetics, Broad Institute
Impact of the Evidence Shortfall on Health Care Costs, Public Budgets, and the Economy
Peter R. Orszag, Ph.D., Director, Congressional Budget Office
10:30 a.m.
QUESTIONS AND DISCUSSION
10:50 a.m.
BREAK
11:10 a.m.
HOW CAN PATIENTS AND PROVIDERS CONTEND WITH THE CHANGES?
Chair: Michael M. E. Johns, M.D., Chancellor, Emory University
Practical Front-Line Challenges and the Future of Expert-Based Care
William W. Stead, M.D., McKesson Foundation Professor of Medicine and Biomedical Informatics, and Associate Vice Chancellor for Strategy and Transformation, Vanderbilt University
The Patient-Physician Partnership in Fostering an Evidence-Driven Environment
Marc Boutin, Esq., Executive Vice President, National Health Council
Information Technology Tools That Support Best Practices by Healthcare Providers
Robert Hayward, M.D., M.P.H., F.R.C.P.C., Associate Professor, Departments of Medicine and Public Health Sciences, and Director, Centre for Health Evidence, University of Alberta
Consumer-Accessible, Web-Based Health Information to Empower Patients
Peter M. Neupert, M.B.A., Corporate Vice President, Health Solutions Group, Microsoft Corporation
12:10 p.m.
QUESTIONS AND DISCUSSION
12:30 p.m.
LUNCH BREAK
OCR for page 175
Evidence-Based Medicine and the Changing Nature of Health Care
2:00 p.m.
WHAT’S NEEDED TO TRANSFORM THE SPEED AND RELIABILITY OF NEW EVIDENCE?
Chair: John W. Rowe, M.D., Professor, Department of Health Policy and Management, Columbia University Mailman School of Public Health
Electronic Health Records and the Prospect of Real-Time Evidence Development
George C. Halvorson, Chairman and Chief Executive Officer, Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals
Research Methods to Speed the Development of Better Evidence
Eric D. Peterson, M.D., M.P.H., Professor of Medicine, Duke Clinical Research Institute
Biopharmaceutical and Medical Device Development: Tailored Therapies Meet Evidence-Based Medicine
Steven M. Paul, M.D., Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company
2:45 p.m.
QUESTIONS AND DISCUSSION
3:00 p.m.
HOW CAN POLICY CHANGES IMPROVE THE VALUE WE GET FROM HEALTH CARE?
Chair: John K. Iglehart, Founding Editor, Health Affairs, and National Correspondent, New England Journal of Medicine
What Is Value in Health Care?
Michael E. Porter, Ph.D., Bishop William Lawrence University Professor, Harvard Business School
Regulatory and Financing Reforms Necessary for Effective Health Care
Donna E. Shalala, Ph.D., President, University of Miami
3:30 p.m.
QUESTIONS AND DISCUSSION
4:00 p.m.
CLOSING REMARKS
Mark B. McClellan, M.D., Ph.D.
Elizabeth G. Nabel, M.D.
OCR for page 176
Evidence-Based Medicine and the Changing Nature of Health Care
This page intentionally left blank.